Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.


Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
04 2019
Historique:
received: 04 12 2018
revised: 31 12 2018
accepted: 05 01 2019
pubmed: 10 2 2019
medline: 25 7 2020
entrez: 10 2 2019
Statut: ppublish

Résumé

Mast cell activation (MCA) accompanies diverse physiologic and pathologic processes and is one of the more frequently encountered conditions in medicine. MCA-related symptoms are usually mild and often transient. In such cases, histamine receptor blockers and other mediator-targeting drugs can usually control MCA. In severe cases, an MCA syndrome (MCAS) may be diagnosed. However, overt MCAS is an unusual condition, and many patients referred because of suspected MCAS are diagnosed with other diseases (autoimmune, neoplastic, or infectious) unrelated to MCA or suffer from MCA-related (eg, allergic) disorders and/or comorbidities without fulfilling criteria of an overt MCAS. These considerations are important as more and more patients are informed that they may have MCA or even MCAS without completing a thorough medical evaluation. In fact, in several instances, symptoms are misinterpreted as MCA/MCAS, and other clinically relevant conditions are not thoroughly pursued. The number of such referrals is increasing. To avoid such unnecessary referrals and to prevent misdiagnoses, we here propose a diagnostic algorithm through which a clinically relevant (systemic) MCA can be suspected and MCAS can subsequently be documented or excluded. In addition, the algorithm proposed should help guide the investigating care providers to consider the 2 principal diagnoses that may underlie MCAS, namely, severe allergy and systemic mastocytosis accompanied by severe MCA. Although validation is required, we anticipate that this algorithm will facilitate the management of patients with suspected MCAS.

Identifiants

pubmed: 30737190
pii: S2213-2198(19)30056-X
doi: 10.1016/j.jaip.2019.01.006
pmc: PMC6643056
mid: NIHMS1518625
pii:
doi:

Substances chimiques

KIT protein, human EC 2.7.10.1
Proto-Oncogene Proteins c-kit EC 2.7.10.1
Tryptases EC 3.4.21.59

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1125-1133.e1

Subventions

Organisme : Intramural NIH HHS
ID : ZIA AI001091-08
Pays : United States

Informations de copyright

Copyright © 2019 American Academy of Allergy, Asthma & Immunology. All rights reserved.

Références

Annu Rev Immunol. 1999;17:931-72
pubmed: 10358778
J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):65-71
pubmed: 10887307
J Immunol. 2000 Nov 15;165(10):5913-20
pubmed: 11067953
Adv Immunol. 2000;76:325-55
pubmed: 11079101
Blood. 2001 Oct 1;98(7):2200-9
pubmed: 11568008
Clin Allergy Immunol. 2002;16:3-42
pubmed: 11577545
Blood. 2001 Oct 15;98(8):2580-3
pubmed: 11588060
J Allergy Clin Immunol. 2002 Jul;110(1):102-9
pubmed: 12110828
Leuk Lymphoma. 2002 May;43(5):1097-105
pubmed: 12148892
Mol Immunol. 2002 Sep;38(16-18):1323-7
pubmed: 12217402
J Exp Med. 1992 Jan 1;175(1):237-44
pubmed: 1370529
Methods. 2004 Mar;32(3):265-70
pubmed: 14962761
Int Arch Allergy Immunol. 2004 Apr;133(4):317-29
pubmed: 15031605
J Allergy Clin Immunol. 2004 Jun;113(6):1086-92
pubmed: 15208589
Clin Exp Med. 2005 Jul;5(2):43-9
pubmed: 16096852
J Allergy Clin Immunol. 2006 Apr;117(4):950-1
pubmed: 16630958
Immunol Allergy Clin North Am. 2006 Aug;26(3):451-63
pubmed: 16931288
Int Arch Allergy Immunol. 2007;142(2):158-64
pubmed: 17057414
J Allergy Clin Immunol. 1991 Sep;88(3 Pt 1):328-38
pubmed: 1716273
Eur J Clin Invest. 2007 Jun;37(6):435-53
pubmed: 17537151
Blood. 2007 Oct 1;110(7):2331-3
pubmed: 17638853
N Engl J Med. 2008 Jan 3;358(1):28-35
pubmed: 18172172
Allergy. 2008 Apr;63(4):480-2
pubmed: 18315738
Curr Opin Allergy Clin Immunol. 2008 Aug;8(4):310-5
pubmed: 18596587
Int Arch Allergy Immunol. 2008;147(4):338-43
pubmed: 18622141
Blood. 2008 Aug 15;112(4):946-56
pubmed: 18684881
J Allergy Clin Immunol. 2009 Mar;123(3):680-6
pubmed: 19135713
Int J Immunopathol Pharmacol. 2008 Oct-Dec;21(4):797-806
pubmed: 19144265
Eur J Clin Invest. 2009 Oct;39(10):914-23
pubmed: 19522836
J Allergy Clin Immunol. 2009 Oct;124(4):639-46; quiz 647-8
pubmed: 19815110
J Invest Dermatol. 2010 Mar;130(3):804-15
pubmed: 19865100
J Allergy Clin Immunol. 2010 Jun;125(6):1269-1278.e2
pubmed: 20434205
Chem Immunol Allergy. 2010;95:45-66
pubmed: 20519881
Eur J Immunol. 2010 Jul;40(7):1843-51
pubmed: 20583030
Clin Exp Allergy. 2010 Dec;40(12):1760-6
pubmed: 20718781
Immunol Today. 1990 Dec;11(12):458-64
pubmed: 2073318
J Allergy Clin Immunol. 2010 Dec;126(6):1099-104.e4
pubmed: 21035176
Clin Exp Allergy. 2011 Mar;41(3):378-88
pubmed: 21255137
Clin Exp Allergy. 2011 Jul;41(7):939-47
pubmed: 21569130
Int Arch Allergy Immunol. 2011;156(2):119-27
pubmed: 21576982
J Allergy Clin Immunol. 2011 Jul;128(1):147-152.e2
pubmed: 21621255
Int Arch Allergy Immunol. 2012;157(3):215-25
pubmed: 22041891
Int Arch Allergy Immunol. 2012;157(3):275-80
pubmed: 22042301
Int Arch Allergy Immunol. 2012;159(1):1-5
pubmed: 22555026
Nat Med. 2012 May 04;18(5):693-704
pubmed: 22561833
Allergy. 2012 Sep;67(9):1118-26
pubmed: 22702477
Allergy. 2012 Oct;67(10):1241-9
pubmed: 22845063
J Allergy Clin Immunol. 2013 Jan;131(1):144-9
pubmed: 23040367
Allergy. 2013 Apr;68(4):417-24
pubmed: 23409940
J Allergy Clin Immunol. 2014 Feb;133(2):520-8
pubmed: 23921094
N Engl J Med. 1987 Jul 2;317(1):30-4
pubmed: 2438554
J Allergy Clin Immunol. 2014 May;133(5):1471-4
pubmed: 24472624
Allergy. 1988;43 Suppl 5:22-31
pubmed: 2451448
Proc Natl Acad Sci U S A. 1989 Jul;86(14):5542-6
pubmed: 2473472
Curr Allergy Asthma Rep. 2014 Aug;14(8):450
pubmed: 24947681
Clin Exp Allergy. 2014 Sep;44(9):1179-87
pubmed: 25039926
J Allergy Clin Immunol. 2015 Jan;135(1):262-4
pubmed: 25091436
Expert Rev Hematol. 2014 Oct;7(5):683-90
pubmed: 25169217
J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):775-8
pubmed: 25439370
Leukemia. 2015 Jun;29(6):1223-32
pubmed: 25650093
Mod Pathol. 2015 Aug;28(8):1138-49
pubmed: 26067933
Curr Allergy Asthma Rep. 2015 May;15(5):22
pubmed: 26139333
N Engl J Med. 2015 Jul 9;373(2):163-72
pubmed: 26154789
J Allergy Clin Immunol. 2016 Jan;137(1):35-45
pubmed: 26476479
Nat Genet. 2016 Dec;48(12):1564-1569
pubmed: 27749843
Allergy. 2017 Nov;72(11):1737-1743
pubmed: 28432683
Allergy. 2017 Dec;72(12):2031-2034
pubmed: 28609557
J Allergy Clin Immunol. 2018 Jan;141(1):180-188.e3
pubmed: 28629749
Genet Med. 2018 Apr;20(5):503-512
pubmed: 28933792
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1368-1372
pubmed: 29258788
Immunol Rev. 2018 Mar;282(1):121-150
pubmed: 29431212
J Clin Immunol. 2018 May;38(4):457-459
pubmed: 29748908
Br J Dermatol. 2018 Oct;179(4):925-932
pubmed: 29787623
J Allergy Clin Immunol. 2018 Sep;142(3):1008-1010
pubmed: 29928922
N Engl J Med. 1987 Jun 25;316(26):1622-6
pubmed: 3295549
J Immunol. 1987 Apr 1;138(7):2184-9
pubmed: 3549898
N Engl J Med. 1983 Dec 29;309(26):1603-5
pubmed: 6646186
J Allergy Clin Immunol. 1994 Dec;94(6 Pt 2):1293-303
pubmed: 7528235
Int Arch Allergy Immunol. 1993;102(2):170-5
pubmed: 7691300
J Allergy Clin Immunol. 1994 May;93(5):817-24
pubmed: 8182221
Ann Fr Anesth Reanim. 1993;12(2):169-72
pubmed: 8368585
J Allergy Clin Immunol. 1997 Jan;99(1 Pt 1):153-4
pubmed: 9003225

Auteurs

Peter Valent (P)

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria. Electronic address: peter.valent@meduniwien.ac.at.

Cem Akin (C)

Division of Allergy and Clinical Immunology, University of Michigan, Ann Arbor, Mich.

Patrizia Bonadonna (P)

Allergy Unit, Verona University Hospital, Verona, Italy.

Karin Hartmann (K)

Department of Dermatology, University of Luebeck, Luebeck, Germany.

Knut Brockow (K)

Department of Dermatology and Allergy Biederstein, Technical University of Munich, Munich, Germany.

Marek Niedoszytko (M)

Department of Allergology, Medical University of Gdansk, Gdansk, Poland.

Boguslaw Nedoszytko (B)

Department of Dermatology, Medical University of Gdansk, Gdansk, Poland.

Frank Siebenhaar (F)

Department of Dermatology & Allergy, Charité Universitätsmedizin Berlin, Berlin, Germany.

Wolfgang R Sperr (WR)

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.

Joanna N G Oude Elberink (JNG)

Department of Allergology, University Medical Center of Groningen, University of Groningen, Groningen, The Netherlands.

Joseph H Butterfield (JH)

Division of Allergic Diseases, Mayo Clinic, Rochester, Minn.

Ivan Alvarez-Twose (I)

Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) and CIBERONC, Hospital Virgen del Valle, Toledo, Spain.

Karl Sotlar (K)

Institute of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria.

Andreas Reiter (A)

III. Medizinische Klinik, Universitäts-Medizin Mannheim, Universität Heidelberg, Mannheim, Germany.

Hanneke C Kluin-Nelemans (HC)

Department of Haematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Olivier Hermine (O)

Imagine Institute Université Paris Descartes, Sorbonne, Paris Cité, Centre national de référence des mastocytoses, Paris, France.

Jason Gotlib (J)

Stanford Cancer Institute/Stanford University School of Medicine, Stanford, Calif.

Sigurd Broesby-Olsen (S)

Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.

Alberto Orfao (A)

Servicio Central de Citometria, Centro de Investigacion del Cancer (IBMCC; CSIC/USAL), IBSAL, CIBERONC and Department of Medicine, University of Salamanca, Salamanca, Spain.

Hans-Peter Horny (HP)

Institute of Pathology, Ludwig-Maximilian University, Munich, Germany.

Massimo Triggiani (M)

Division of Allergy and Clinical Immunology, University of Salerno, Salerno, Italy.

Michel Arock (M)

Department of Hematological Biology, Pitié-Salpêtrière Hospital, Pierre et Marie Curie University (UPMC), Paris, France.

Lawrence B Schwartz (LB)

Department of Internal Medicine, Division of Rheumatology, Allergy & Immunology, Virginia Commonwealth University, Richmond, Va.

Dean D Metcalfe (DD)

Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH